Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT03610971||Not yet recruiting||Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors||
||Other / Industry||
||40||All||18 Years and older (Adult, Older Adult)||NCT03610971||MCC-19660
|July 2019||January 2021||January 2022||August 1, 2018||May 6, 2019||